Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Cyprotex Plc

2 Nov 2016 10:09

RNS Number : 1336O
Nplus1 Singer Capital Markets Ltd
02 November 2016
 

FORM 8.5 (EPT/RI)

 

This disclosure replaces RNS 4994N which was disclosed in error.

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cyprotex Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Cyprotex Plc

 

(d) Date dealing undertaken:

01 November 2016

 

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

Purchase

 

11653

 

 

156.64p

 

156.64p

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

02 November 2016

Contact name:

Damian Fernandez

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBTBMTMBMMBFF
Date   Source Headline
18th Jun 20101:16 pmRNSHolding(s) in Company
21st Apr 20107:00 amRNSFrench Research Tax Credit Accreditation
15th Apr 20107:00 amRNSUS Business Development Executive Appointment
18th Mar 20107:00 amRNSEnd of Offer Period
17th Mar 20107:00 amRNSFinal Results
16th Mar 20106:10 pmRNSRule 8.3- Cyprotex PLC
3rd Mar 201010:06 amPRNRule 8.3 - Cyprotex
2nd Mar 201012:48 pmRNSRule 2.10 Announcement
2nd Mar 20107:00 amRNSStatement re Unsolicited Approach
17th Feb 20104:05 pmRNSNominated Adviser Change of Name
29th Jan 20107:00 amRNSTrading Statement
5th Jan 20107:00 amRNSTrading Update
25th Nov 200912:37 pmRNSDirector/PDMR Shareholding
20th Nov 20097:00 amRNSStatement re Trading
17th Nov 20092:37 pmRNSIssue of Equity
18th Sep 20094:29 pmRNSDirectors Dealing
12th Aug 20097:00 amRNSHalf Yearly Report
14th Jul 20098:00 amRNSAGM Statement
7th May 20097:00 amRNSLaunch of Cloe Gateway Web Portal
31st Mar 20097:00 amRNSAppointment of new CCO
17th Mar 20097:00 amRNSFinal Results
11th Mar 20093:39 pmRNSNotice of Results
6th Mar 20094:02 pmRNSHolding(s) in Company
25th Feb 20097:00 amRNSDirectorate Change
5th Feb 20097:00 amRNSChange of Adviser
23rd Jan 20097:00 amRNSTrading Statement
5th Jan 200912:55 pmRNSDirectorate Change
6th Nov 200812:42 pmRNSTrading Statement
5th Sep 20088:54 amRNSDirector/PDMR Shareholding
5th Sep 20087:30 amRNSDirector/PDMR Shareholding
29th Aug 200810:25 amRNSAppointment of New Chairman
28th Aug 20087:00 amRNSInterim Results
27th Aug 200812:52 pmRNSResult of Placing and Open Of
6th Aug 20084:04 pmRNSIssue of Equity
15th Jul 20082:25 pmRNSResult of AGM
14th Jul 200810:00 amRNSAGM Statement
24th Jun 20087:30 amRNSDirector resignation
20th Jun 20087:30 amRNSShare placement
19th Jun 200811:00 amRNSAnnual Report and Accounts
3rd Jun 20083:33 pmRNSAppointment of CEO
24th Apr 20087:00 amRNSPreliminary results
21st Apr 20087:30 amRNSPrelim results announcement
20th Mar 200812:47 pmRNSChairman appointment
25th Feb 20087:00 amRNSPartnership
20th Feb 20084:40 pmRNSHolding(s) in Company
21st Dec 20073:54 pmRNSDirector/PDMR Shareholding
17th Dec 20077:00 amRNSTrading Statement
30th Nov 20078:00 amRNSTotal Voting Rights
28th Nov 200711:11 amRNSDirector/PDMR Shareholding
23rd Nov 20071:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.